Novo Nordisk Company

Novo Nordisk is a pharmaceutical manufacturing company that specializes in Insulin, obesity, rare diseases, and diabetes.

Invests into


Connections from

Technology: Biotechnology, Health Care, Science and Engineering
Industry: Investor, Pharma, end-to-end drug development
Headquarters: Bagsværd, Hovedstaden, Denmark
Zip: 10001+
Founded Date: 1923-01-01
Employees Number: 10001+
Funding Status: IPO
Acquisitions Number: 8
Investors Number: 22000000
Total Funding: 22000000
Estimated Revenue: $10B+
Last Funding Date: 2018-12-05
Last Funding Type: Post-IPO Equity

Visit Website
webmasters@novonordisk.com
http://twitter.com/novonordisk
Register and Claim Ownership